Clinical Trial Update: Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial of ruxolitinib phosphate for recurrent/ refractory diffuse large B-cell lymphoma and mature T-/NK-cell non-Hodgkin lymphoma after stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mature T-cell Non-hodgkin Lymphoma
• Nk-cell Non-hodgkin Lymphoma

Drugs mentioned

• Ruxolitinib phosphate (ruxolitinib phosphate)

Snippet

Sponsor: University of Nebraska | Conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-24